Joel A. Lardizabal, MD

Review

The Balance Between Anti-ischemic Efficacy and Bleeding Risk of Antithrombotic Therapy in Percutaneous Coronary Intervention: A

06/03/2010

Joel A. Lardizabal , MD;

Bipin K. Joshi , MD;

John A. Ambrose , MD;

ABSTRACT: Background. The development of newer and more potent antithrombotic agents and strategies has markedly reduced cardiovascular mortality and ischemic complications in patients with acute coronary syndromes and those undergoing...

ABSTRACT: Background. The...

06/03/2010

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Joel A. Lardizabal, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products